Stomogyl
Stomorgyl Tablets are indicated for the treatment of periodontal and related oral conditions in cats and dogs. They contain Spiramycin of standard potency (3,200IU/mg) and metronidazole.
Stomorgyl is presented as pink circular convex tablets that have been scored for easy and accurate dosing. They are available in different strengths and have been film-coated to help with their palatability.
Contraindications
Do not use in animals with a known hypersensitivity to spiramycin or metronidazole.
Special Warnings for Each Target Species
None
Special Precautions for Use in Animals
None
Special Precautions to be Taken by the Person Administering the Product to Animals
In case of accidental ingestion obtain medical advice if needed. Wash hands after use. Should direct skin contact occur, wash affected area. Should accidental eye exposure occur, flush the eyes immediately with water and seek medical attention if needed.
Adverse Reactions
None known.
Use During Pregnancy, Lactation or Lay
Safety in pregnant dogs and cats has not been demonstrated.
Interactions
The product should not be used concurrently with other antibiotics of the macrolide group.
Amounts to be Administered and Administration Route
By oral administration. For dogs and cats, 23.4 mg spiramycin and 12.5 mg metronidazole/kg bodyweight, once daily for up to 5 to 10 days.
Stomorgyl 2: 1 tablet/2 kg bodyweight once daily for 5-10 days.
Stomorgyl 10: 1 tablet/10 kg bodyweight once daily for 5-10 days.
Stomorgyl 20: equivalent to 1 tablet/20 kg bodyweight once daily for 5-10 days.
Do not break or crush the tablets.
Overdose
No signs of toxicity were seen in cats receiving 5 times the recommended dose, or in dogs receiving 8 times the recommended dose.
Pharmaceutical Particulars
Excipients: Aluminium Oxide (hydrated), Sorbitol, Dextrin (white), Gelatin, Citric acid monohydrate, Magnesium stearate, Wheat starch, Ponceau 4R (E124), Titanium dioxide (E171), Hypromellose 6 m Pa s, Polyethylene glycol 2000.
Major Incompatibilities
None known.